The company generates zero operating revenue while maintaining an elevated administrative burn rate, evidenced by quarterly SG&A expenses that reached $324.8K in 2025Q4.
| Sales/Revenue | 0 | - | - |
| Revenue Growth % | - | - | - |
| Cost of Goods Sold | 0 | - | - |
| COGS % of Revenue | - | - | - |
| Gross Profit | 0 | 0 | 0 |
| Gross Margin % | - | - | - |
| Gross Profit Growth % | - | - | - |
| Operating Expenses | 891.28K | 1.01M | 575.71K |
| OpEx % of Revenue | - | - | - |
| Selling, General & Admin | 891.28K | 1.01M | 575.71K |
| SG&A % of Revenue | - | - | - |
| Research & Development | 0 | - | - |
| R&D % of Revenue | - | - | - |
| Other Operating Expenses | 0 | - | - |
| Operating Income | -891.75K | -1.01M | -575.71K |
| Operating Margin % | - | - | - |
| Operating Income Growth % | - | -74.71% | - |
| EBITDA | 1.59M | -1.01M | 4.75M |
| EBITDA Margin % | - | - | - |
| EBITDA Growth % | -16.74% | -121.19% | - |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 |
| EBIT | 1.59M | -1.01M | 4.75M |
| Net Interest Income | -308.69K | 9.8M | 5.32M |
| Interest Income | -308.69K | 9.8M | 5.32M |
| Interest Expense | 0 | 0 | 0 |
| Other Income/Expense | 0 | - | - |
| Pretax Income | 8.6M | 8.79M | 4.75M |
| Pretax Margin % | - | - | - |
| Income Tax | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% |
| Net Income | 8.6M | 8.79M | 4.75M |
| Net Margin % | - | - | - |
| Net Income Growth % | 22.82% | 85.16% | - |
| Net Income (Continuing) | 8.6M | 8.79M | 4.75M |
| Discontinued Operations | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 |
| EPS (Diluted) | 0.37 | 0.29 | 0.15 |
| EPS Growth % | 22.13% | 93.33% | - |
| EPS (Basic) | - | 0.29 | 0.15 |
| Diluted Shares Outstanding | 23M | 23M | 30.67M |
| Basic Shares Outstanding | 23M | 23M | 30.67M |
| Dividend Payout Ratio | - | - | - |
Liquidation risk before merger
As reported in financial statements, SIMAW's quarterly SG&A expenses peaked at $324.8K in 2025Q4, reflecting the ongoing costs of maintaining a public shell entity while the sponsor continues to search for a viable healthcare target within the competitive and increasingly difficult acquisition landscape.
The company's cost structure is entirely comprised of administrative and regulatory overhead, which appears to be scaling without any corresponding revenue generation. Investors should monitor whether these recurring expenses will deplete the remaining cash reserves before a definitive merger agreement can be secured.
Based on the provided income statement data, SIMAW has consistently reported positive net income figures, such as the $2.0M recorded in 2026Q1, despite generating zero operating revenue, which suggests these earnings are driven by non-operating items like interest income from the trust account.
The disconnect between negative operating income and positive net income highlights the reliance on interest-bearing assets rather than core business performance. This accounting dynamic warrants further investigation, as it may provide a misleading impression of the company's underlying financial health to unsophisticated market participants.
According to recent SEC filings, SIMAW's operating income has remained consistently negative since inception, with 2026Q1 showing a loss of $126.9K, confirming that the entity lacks the operational scale or revenue-generating capacity required to achieve positive operating leverage in its current pre-combination state.
The absence of revenue means that any increase in SG&A directly exacerbates the operating loss, leaving the company entirely dependent on the sponsor's ability to execute a transaction. The current trajectory suggests that the firm is essentially a cost-center until a business combination is finalized.
As indicated by the reported cash balance of $65,427, SIMAW appears to be operating with a very limited liquidity buffer, which may constrain the sponsor's ability to conduct thorough due diligence on potential healthcare targets as the 18-24 month merger window continues to close.
Short-sellers might focus on the potential for a liquidity crunch, which could force management into a suboptimal merger to avoid liquidation. The current cash position suggests that the company may require additional capital injections or sponsor support to maintain its listing status in the near term.
Quick answers to the most common questions about buying SIMAW stock.
SIM Acquisition Corp. I (SIMAW) is profitable, generating $8.8M in net income for the fiscal year ending 2025.